Wolverine Trading’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-16,300
Closed -$231K 4836
2020
Q2
$231K Buy
+16,300
New +$222K ﹤0.01% 3660
2019
Q3
Sell
-21,000
Closed -$306K 4656
2019
Q2
$306K Buy
21,000
+1,700
+9% +$24.1K ﹤0.01% 3243
2019
Q1
$271K Buy
+19,300
New +$313K ﹤0.01% 3484
2018
Q4
Sell
-17,200
Closed -$262K 4861
2018
Q3
$262K Buy
17,200
+800
+5% +$11.5K ﹤0.01% 3912
2018
Q2
$273K Hold
16,400
﹤0.01% 3920
2018
Q1
$273K Buy
+16,400
New +$253K ﹤0.01% 3920
2017
Q4
Sell
-15,600
Closed -$220K 5171
2017
Q3
$220K Buy
+15,600
New +$206K ﹤0.01% 3680
2016
Q4
Sell
-21,100
Closed -$229K 4753
2016
Q3
$229K Buy
21,100
+4,600
+28% +$53.7K ﹤0.01% 3633
2016
Q2
$175K Buy
+16,500
New +$195K ﹤0.01% 3363

Other funds holding INVA

Wolverine Trading's INVA Position: Q1 2024 in Review

Wolverine Trading sold out of Innoviva (INVA) in Q1 2024, closing a stake of 12,212 shares — an estimated $196K sold.

Wolverine Trading first reported a position in INVA in Q1 2017 and held it in 10 quarters. The position peaked at $475K in Q1 2017. 217 funds tracked by Wall St. Rank hold INVA as of Q1 2024.

  • Wolverine Trading reported no remaining Innoviva position as of Q1 2024 after selling out during the quarter.
  • Wolverine Trading sold 12,212 Innoviva shares in Q1 2024, an estimated $196K.
  • Wolverine Trading first reported a position in Innoviva in Q1 2017 and held it in 10 quarters.
  • Wolverine Trading's Innoviva position peaked at $475K in Q1 2017.
  • 217 funds tracked by Wall St. Rank held Innoviva as of Q1 2024.

Based on Wolverine Trading's 13F filing for Q1 2024, filed 15 May 2024.